Researcher
Hendrik Jan Thibaut
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 2006 → Today
Projects
1 - 1 of 1
- Uncovering kinase inhibitor resistance mechanisms via CRISPR-based gain-of-function mutagenesis.From12 Jul 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
11 - 20 of 64
- Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models(2022)
Authors: Ji Ma, Sander Jansen, Birgit Weynand, Patrick Matthys, Tania Roskams, Johan Neyts, Hendrik Jan Thibaut, Kai Dallmeier
- Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model(2022)
Authors: Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Winnie Kerstens, Madina Rasulova, Sam Noppen, Rana Abdelnabi, Piet Maes, et al.
- Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate(2022)
Authors: Li-Hsin Li, Laurens Liesenborghs, Sander Jansen, Hendrik Jan Thibaut, Johan Neyts, Leen Delang, Kai Dallmeier
Pages: 215 - 224 - High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium(2022)
Authors: Bas Calcoen, Winnie Kerstens, Maya Imbrechts, Thomas Vercruysse, Kai Dallmeier, Johan Van Weyenbergh, Piet Maes, Xavier Bossuyt, Hendrik Jan Thibaut, Karen Vanhoorelbeke, et al.
- A High-Throughput Yellow Fever Neutralization Assay(2022)
Authors: Madina Rasulova, Thomas Vercruysse, Ji Ma, Jolien Timmermans, Li-Hsin Li, Lotte Coelmont, Johan Neyts, Kai Dallmeier, Hendrik Jan Thibaut
- MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters(2022)
Authors: Robbert Boudewijns, Thomas Vercruysse, Hendrik Jan Thibaut, Birgit Weynand, Lotte Coelmont, Johan Neyts, Kai Dallmeier
- Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings(2022)
Authors: Tine Tricot, Hendrik Jan Thibaut, Kayvan Abbasi, Manoj Kumar Gautam, Johan Neyts, Catherine Verfaillie
- Use of Micro-Computed Tomography to Visualize and Quantify COVID-19 Vaccine Efficiency in Free-Breathing Hamsters(2021)
Authors: Laura Seldeslachts, Christopher Cawthorne, Suzanne Kaptein, Robbert Boudewijns, Hendrik Jan Thibaut, Sapna Sharma, Georg Schramm, Birgit Weynand, Kai Dallmeier, Greetje Vande Velde
Pages: 177 - 192Number of pages: 16 - An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models(2021)
Authors: Lana Langendries, Sofie Jacobs, Sebastiaan ter Horst, Laura Seldeslachts, Laurens Liesenborghs, Robbert Boudewijns, Hendrik Jan Thibaut, Kai Dallmeier, Greetje Vande Velde, Birgit Weynand, et al.
- Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19(2021)
Authors: Laura Vangeel, Thomas Vercruysse, Hendrik Jan Thibaut, Pieter Leyssen
Patents
1 - 10 of 10
- Coronavirus vaccines (Inventor)
- Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)
- Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)